| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/08/2009 | US20090011468 Method for improving protein production |
| 01/08/2009 | US20090011467 Novel fructosyl peptide oxidase |
| 01/08/2009 | US20090011466 Concatameric immunoadhesion molecule |
| 01/08/2009 | US20090011465 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells |
| 01/08/2009 | US20090011464 Humanized immunoglubulin reactive with alph4beta7 integrin |
| 01/08/2009 | US20090011463 Pcka Modifications and Enhanced Protein Expression in Bacillus |
| 01/08/2009 | US20090011462 Polypeptides having Lipase Activity and Polynucleotides Encoding Same |
| 01/08/2009 | US20090011461 Human Spasmolytic Polypeptide in Glycosylated Form |
| 01/08/2009 | US20090011460 Calcium-binding photoprotein, gene encoding the same, and use thereof |
| 01/08/2009 | US20090011453 Methods for Producing Proteins Using Hamster Igf-1 |
| 01/08/2009 | US20090011434 Methods And Compositions For Diagnosing Breast Cancer |
| 01/08/2009 | US20090011421 Susceptibility to bone damage |
| 01/08/2009 | US20090011415 Regulation of neuronal expression of apolipoprotein e |
| 01/08/2009 | US20090011411 Method for Detecting and Quantifying Endogenous Wheat Dna Sequence |
| 01/08/2009 | US20090011402 Detecting an effector or cofactor aggregate; nucleic acid enzyme and polynucleotide substrate;first set of particles comprising a second polynucleotide complementary to substrate; second set of particles comprising a third polynucleotide complementary to substrate; tail-to-tail hybridization |
| 01/08/2009 | US20090011400 Substrate switched ammonia lyases and mutases |
| 01/08/2009 | US20090011113 Diacylglycerol acyltransferase nucleic acid sequences and associated products |
| 01/08/2009 | US20090011080 Gene encoding protein responsible for flocculation property of yeast and use thereof |
| 01/08/2009 | US20090011036 Drug containing hollow protein nanoparticles of particle-forming protein, fused with disease-treating target-cell-substance |
| 01/08/2009 | US20090011000 Inhibitors of Infection |
| 01/08/2009 | US20090010996 Human antibiotic proteins |
| 01/08/2009 | US20090010963 Raccoon Poxvirus Expressing Rabies Glycoproteins |
| 01/08/2009 | US20090010961 Avirulent, immunogenic flavivirus chimeras |
| 01/08/2009 | US20090010960 Bacteriophage-mediated immunisation against hepatitis |
| 01/08/2009 | US20090010953 Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods |
| 01/08/2009 | US20090010951 Epitope/Peptide Recognized By Hla-A2402-Restricted Ep/Cam-Specific Ctl And Use Of The Same |
| 01/08/2009 | US20090010948 Anti-tumor vaccines delivered by dendritic cells devoid of interleukin-10 |
| 01/08/2009 | US20090010947 Red Microalgae Expressing Exogenous Polypeptides And Methods Of Generating And Utilizing Same |
| 01/08/2009 | US20090010946 Novel Stromal Cell-Derived Factor-1 Polypeptides, Polynucleotides, Modulators Thereof and Methods of Use |
| 01/08/2009 | US20090010942 Novel primate chitinases and uses therefor |
| 01/08/2009 | US20090010936 Novel Stra6 Polypeptides |
| 01/08/2009 | US20090010934 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 01/08/2009 | US20090010933 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors |
| 01/08/2009 | US20090010930 Antibodies to vla-1 |
| 01/08/2009 | US20090010925 Antibody variants |
| 01/08/2009 | US20090010924 Apoptotic Anti-IgE Antibodies |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010907 Dnazymes for Inhibition of Japanese Encephalitis Virus Replication |
| 01/08/2009 | US20090010888 Use of cytochrome P450 reductase as insecticidal target |
| 01/08/2009 | US20090010879 Receptor Based Antagonists and Methods of Making and Using |
| 01/08/2009 | US20090010875 IL-7 Fusion Proteins |
| 01/08/2009 | US20090010872 Chimeric soluble hyper il-11 and use thereof |
| 01/08/2009 | US20090010871 Method for Production of a Transformed Cell |
| 01/08/2009 | US20090010848 Recombinant Peptides Derived from the Mc3 Anti-BA46 Antibody, Methods of Use Thereof, and Methods of Humanizing Antibody Peptides |
| 01/08/2009 | US20090010847 Connective Tissue Growth Factor-4 |
| 01/08/2009 | US20090010842 Methods for the early diagnosis of ovarian cancer |
| 01/08/2009 | US20090010841 Antiproliferative agents; as chimeric molecules to direct an effector (e.g. a cytotoxin, an imaging reagent, a drug, etc.) to a prostate tumor site; single chain antibody |
| 01/08/2009 | US20090010840 BISPECIFIC SINGLE CHAIN Fv ANTIBODY MOLECULES AND METHODS OF USE THEREOF |
| 01/08/2009 | DE102007031574A1 Minor-Spleißosom Testsystem zur Modulierung der Zellteilung Minor spliceosome test system for modulating cell division |
| 01/08/2009 | CA2707436A1 Copy dna and sense rna |
| 01/08/2009 | CA2694354A1 Lactic acid bacteria-derived double-stranded rna |
| 01/08/2009 | CA2692603A1 Peptides facilitating retrograde transport and their uses |
| 01/08/2009 | CA2692503A1 Dsrna for treating viral infection |
| 01/08/2009 | CA2692501A1 Hyperactive variants of the transposase protein of the transposon system sleeping beauty |
| 01/08/2009 | CA2692478A1 Treatment of influenza |
| 01/08/2009 | CA2692320A1 Methods of treating bone disorders with modulators of axl |
| 01/08/2009 | CA2692257A1 Modification of plant flavonoid metabolism |
| 01/08/2009 | CA2691964A1 Androgen-dependent 1-f-aromatase reporter gene |
| 01/08/2009 | CA2691962A1 Hybrid operon for expression of colonization factor (cf) antigens of enterotoxigenic escherichia coli |
| 01/08/2009 | CA2691868A1 Immortalized avian cell lines |
| 01/08/2009 | CA2691825A1 Plasmid-encoded neurotoxin genes in clostridium botulinum serotype a subtypes |
| 01/08/2009 | CA2691734A1 Anti-muc17 antibody |
| 01/08/2009 | CA2691626A1 Pseudomonas aeruginosa-outer membrane protein pa4710 |
| 01/08/2009 | CA2691440A1 Methods for altering the genome of a monocot plant cell |
| 01/08/2009 | CA2691378A1 Compositions and methods for treating and diagnosing cancer |
| 01/08/2009 | CA2691374A1 Recombinant c-terminal .alpha.-amidating enzyme derivative |
| 01/08/2009 | CA2690563A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/08/2009 | CA2690538A1 Par-2 binding antibodies |
| 01/08/2009 | CA2690492A1 Method of producing lactic acid |
| 01/08/2009 | CA2690475A1 Promoter |
| 01/08/2009 | CA2689125A1 Heavy chain mutant leading to improved immunoglobulin production |
| 01/08/2009 | CA2687442A1 Plants with altered root architecture, involving the rt1 gene, related constructs and methods |
| 01/07/2009 | EP2012246A1 Method of predicting the secondary structure of rna, prediction apparatus and prediction program |
| 01/07/2009 | EP2012122A1 Mutated parvovirus structural proteins as vaccines |
| 01/07/2009 | EP2011889A1 Methods for measuring drug resistance against HCV |
| 01/07/2009 | EP2011888A1 Nucleotide sequences resulting from the genome of the HIV-1, HIV-2 and SIV retroviruses, and their applications in particular for amplifying the genomes of these retroviruses and for in vitro diagnosis of infections caused by these viruses |
| 01/07/2009 | EP2011886A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/07/2009 | EP2011884A1 DNA diagnostics based on mass spectrometry |
| 01/07/2009 | EP2011883A1 Method of predicting skin spot formation and method of screening skin spot formation inhibitor with the use of spot site-increasing genes as indication |
| 01/07/2009 | EP2011882A1 Method for screening of substance capable of increasing glutathione |
| 01/07/2009 | EP2011881A1 Androgen-dependent gene fusion comprising the 1f aromatase promoter and a reporter gene |
| 01/07/2009 | EP2011878A1 Vectors for cloning |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011876A1 Dna vaccine for koi herpes virus (khv) disease |
| 01/07/2009 | EP2011875A1 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 01/07/2009 | EP2011874A1 Recombinant gelatin in vaccines |
| 01/07/2009 | EP2011873A2 Tumor necrosis factor receptor-associated factors |
| 01/07/2009 | EP2011872A1 Instrument and method for nucleic acid isolation |
| 01/07/2009 | EP2011871A1 Primer and probe for detection of mycobacterium intracellulare, and method for detection of mycobacterium intracellulare by using the primer and probe |
| 01/07/2009 | EP2011870A1 Mutant polypeptide having effector function |
| 01/07/2009 | EP2011869A1 Novel anti-cd98 antibody |
| 01/07/2009 | EP2011868A1 Modified creatinine amide hydrolase having improved affinity for substrate, and reagent composition for determination of creatinine |
| 01/07/2009 | EP2011867A1 Pseudomonas aeruginosa outer membrane protein pa0427 |
| 01/07/2009 | EP2011866A1 Method for the generation of a non-human animal with an oncogene |
| 01/07/2009 | EP2011864A1 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 01/07/2009 | EP2011862A1 Method for manufacturing an active component of a medicine or diagnosis agent in MDCJ cell suspension culture |
| 01/07/2009 | EP2011861A1 Bacterium capable of producing purine substance, and process for production of purine substance |
| 01/07/2009 | EP2011860A1 Bacterium capable of producing purine substance, and process for production of purine substance |
| 01/07/2009 | EP2011858A1 A bile resistant bacillus composition secreting high levels of phytase |
| 01/07/2009 | EP2011802A2 Anti-CD40 monoclonal antibody |